Repligen Corp (RGEN) Q3 2024: Everything You Need to Know Ahead of Earnings

Author's Avatar
Nov 11, 2024
Article's Main Image

Repligen Corp (RGEN, Financial) is set to release its Q3 2024 earnings on Nov 12, 2024. The consensus estimate for Q3 2024 revenue is $153.23 million, and the earnings are expected to come in at $0.07 per share. The full year 2024's revenue is expected to be $628.98 million and the earnings are expected to be $0.54 per share. More detailed estimate data can be found on the Forecast page.

Repligen Corp (RGEN, Financial) Estimates Trends

Over the past 90 days, revenue estimates for Repligen Corp (RGEN) for the full year 2024 have increased from $626.57 million to $628.98 million. However, the revenue estimates for 2025 have declined from $707.86 million to $705.25 million. Earnings estimates have also shown a positive trend for the full year 2024, rising from $0.39 per share to $0.54 per share, while the estimates for 2025 have slightly decreased from $1.05 per share to $1.02 per share.

Repligen Corp (RGEN, Financial) Reported History

In the previous quarter of 2024-06-30, Repligen Corp's (RGEN) actual revenue was $154.07 million, which missed analysts' revenue expectations of $154.121 million by -0.03%. Repligen Corp's (RGEN) actual earnings were $0.06 per share, which missed analysts' earnings expectations of $0.131 per share by -54.2%. After releasing the results, Repligen Corp (RGEN) was up by 16.37% in one day.

1855944675509301248.png

Repligen Corp (RGEN, Financial) 12 Month Price Targets

Based on the one-year price targets offered by 13 analysts, the average target price for Repligen Corp (RGEN) is $193.06 with a high estimate of $225 and a low estimate of $160. The average target implies an upside of 37.27% from the current price of $140.64.

Based on GuruFocus estimates, the estimated GF Value for Repligen Corp (RGEN, Financial) in one year is $170.68, suggesting an upside of 21.36% from the current price of $140.64.

Based on the consensus recommendation from 16 brokerage firms, Repligen Corp's (RGEN, Financial) average brokerage recommendation is currently 1.9, indicating an "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.

1855944758581686272.png

This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.

Disclosures

I/We may personally own shares in some of the companies mentioned above. However, those positions are not material to either the company or to my/our portfolios.